NO308234B1 - Farmasøytisk olje-i-vann-emulsjon med antivirusaktivitet inneholdende 9-[(2-hydroksyetoksy)-metyl]guanidin (acyclovir) eller et salt eller en ester derav - Google Patents

Farmasøytisk olje-i-vann-emulsjon med antivirusaktivitet inneholdende 9-[(2-hydroksyetoksy)-metyl]guanidin (acyclovir) eller et salt eller en ester derav

Info

Publication number
NO308234B1
NO308234B1 NO950895A NO950895A NO308234B1 NO 308234 B1 NO308234 B1 NO 308234B1 NO 950895 A NO950895 A NO 950895A NO 950895 A NO950895 A NO 950895A NO 308234 B1 NO308234 B1 NO 308234B1
Authority
NO
Norway
Prior art keywords
acyclovir
ester
salt
hydroxyethoxy
methyl
Prior art date
Application number
NO950895A
Other languages
English (en)
Norwegian (no)
Other versions
NO950895D0 (no
NO950895L (no
Inventor
Knud Erik Gebhard-Hansen
Soeren Bols Pedersen
Karen Bjoernsdottir
Bodil Gyllembourg Lissau
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of NO950895D0 publication Critical patent/NO950895D0/no
Publication of NO950895L publication Critical patent/NO950895L/no
Publication of NO308234B1 publication Critical patent/NO308234B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO950895A 1992-09-09 1995-03-08 Farmasøytisk olje-i-vann-emulsjon med antivirusaktivitet inneholdende 9-[(2-hydroksyetoksy)-metyl]guanidin (acyclovir) eller et salt eller en ester derav NO308234B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
PCT/DK1993/000288 WO1994005258A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof

Publications (3)

Publication Number Publication Date
NO950895D0 NO950895D0 (no) 1995-03-08
NO950895L NO950895L (no) 1995-03-08
NO308234B1 true NO308234B1 (no) 2000-08-21

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950895A NO308234B1 (no) 1992-09-09 1995-03-08 Farmasøytisk olje-i-vann-emulsjon med antivirusaktivitet inneholdende 9-[(2-hydroksyetoksy)-metyl]guanidin (acyclovir) eller et salt eller en ester derav

Country Status (27)

Country Link
EP (1) EP0662819B1 (de)
JP (1) JPH08501089A (de)
AT (1) ATE137113T1 (de)
AU (1) AU4945393A (de)
BG (1) BG62032B1 (de)
BR (1) BR9307024A (de)
CA (1) CA2142493A1 (de)
CZ (1) CZ284007B6 (de)
DE (1) DE69302396T2 (de)
DK (1) DK169121B1 (de)
EE (1) EE03088B1 (de)
ES (1) ES2086235T3 (de)
FI (1) FI112777B (de)
GR (1) GR3019984T3 (de)
HR (1) HRP931160B1 (de)
HU (1) HUT72606A (de)
LT (1) LT3056B (de)
LV (1) LV10912B (de)
NO (1) NO308234B1 (de)
PL (1) PL172663B1 (de)
RO (1) RO113306B1 (de)
RU (1) RU2128503C1 (de)
SI (1) SI9300469A (de)
SK (1) SK280119B6 (de)
UA (1) UA41897C2 (de)
WO (1) WO1994005258A1 (de)
ZA (1) ZA936661B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
FR2753626B1 (fr) * 1996-09-20 1998-11-06 Centre International De Rech Dermatologiques Galderma Cird Galderma Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
JP2007532697A (ja) * 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008006085A2 (en) * 2006-07-07 2008-01-10 University Of Washington Compositions and methods for predicting inhibitors of protein targets
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2658551B1 (de) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Behandlung von erektionsstörungen und anderen indikationen
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
DK111392A (da) 1994-03-10
RU2128503C1 (ru) 1999-04-10
LV10912B (en) 1996-08-20
EP0662819A1 (de) 1995-07-19
HRP931160A2 (en) 1995-12-31
BR9307024A (pt) 1999-06-29
LTIP959A (en) 1994-05-15
SK280119B6 (sk) 1999-08-06
NO950895D0 (no) 1995-03-08
GR3019984T3 (en) 1996-08-31
DK111392D0 (da) 1992-09-09
CZ284007B6 (cs) 1998-07-15
UA41897C2 (uk) 2001-10-15
DE69302396D1 (de) 1996-05-30
PL307860A1 (en) 1995-06-26
FI112777B (fi) 2004-01-15
NO950895L (no) 1995-03-08
PL172663B1 (pl) 1997-10-31
LV10912A (lv) 1995-12-20
LT3056B (en) 1994-10-25
HU9500702D0 (en) 1995-04-28
FI951086A7 (fi) 1995-03-08
HUT72606A (en) 1996-05-28
ATE137113T1 (de) 1996-05-15
BG99484A (bg) 1995-12-29
DE69302396T2 (de) 1996-08-14
ES2086235T3 (es) 1996-06-16
DK169121B1 (da) 1994-08-22
WO1994005258A1 (en) 1994-03-17
SI9300469A (en) 1994-03-31
JPH08501089A (ja) 1996-02-06
AU4945393A (en) 1994-03-29
EE03088B1 (et) 1998-06-15
EP0662819B1 (de) 1996-04-24
RO113306B1 (ro) 1998-06-30
ZA936661B (en) 1994-05-20
SK29195A3 (en) 1997-01-08
RU95110930A (ru) 1997-03-27
CA2142493A1 (en) 1994-03-17
FI951086A0 (fi) 1995-03-08
BG62032B1 (bg) 1999-01-29
CZ59995A3 (en) 1995-09-13
HRP931160B1 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
NO950895L (no) Farmasöytisk olje-i-vann-emulsjon med antivirusaktivitet inneholdende 9-[(2-hydroksyetoksy)-metylÅguanidin (acyclovir) eller et salt eller en ester derav
US4963555A (en) Formulations of heterocyclic compounds
EP0044543B1 (de) Äusserlich anzuwendende Zubereitungen mit 9-(2-Hydroxyethoxymethyl) guanin
KR920021139A (ko) 약학 조성물
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
RU2000112410A (ru) Стабильные косметические композиции
EP0511991B1 (de) Penciclovir enthaltende pharmazeutische formulierung
EP0593562B1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
IE902819A1 (en) Pharmaceutical formulation
HK1012242B (en) Topical composition containing penciclovir
TH420B (th) การจัดสูตรผสมของสารประกอบเฮเทอโรไซลิค

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees